Geode Capital Management
ETON icon

Geode Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Geode Capital Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.6M Buy
652,303
+74,637
+13% +$2.19M ﹤0.01% 2058
2026
Q1 		$14.3M Buy
577,666
+12,615
+2% +$221K ﹤0.01% 2183
2025
Q4 		$9.56M Sell
565,051
-8,979
-2% -$158K ﹤0.01% 2433
2025
Q3 		$12.5M Sell
574,030
-18,835
-3% -$313K ﹤0.01% 2284
2025
Q2 		$8.45M Buy
592,865
+294,617
+99% +$4.66M ﹤0.01% 2463
2025
Q1 		$3.87M Buy
298,248
+29,602
+11% +$447K ﹤0.01% 2771
2024
Q4 		$3.58M Sell
268,646
-4,050
-1% -$41.1K ﹤0.01% 2907
2024
Q3 		$1.64M Buy
272,696
+32,365
+13% +$137K ﹤0.01% 3191
2024
Q2 		$791K Buy
240,331
+6,164
+3% +$21.6K ﹤0.01% 3397
2024
Q1 		$878K Buy
234,167
+6,911
+3% +$30.2K ﹤0.01% 3411
2023
Q4 		$996K Buy
227,256
+9,627
+4% +$38.6K ﹤0.01% 3361
2023
Q3 		$908K Buy
217,629
+7,537
+4% +$29.1K ﹤0.01% 3365
2023
Q2 		$733K Buy
210,092
+23,510
+13% +$86.5K ﹤0.01% 3475
2023
Q1 		$718K Hold
186,582
– – ﹤0.01% 3506
2022
Q4 		$522K Sell
186,582
-389
-0.2% -$1.05K ﹤0.01% 3643
2022
Q3 		$392K Hold
186,971
– – ﹤0.01% 3856
2022
Q2 		$489K Hold
186,971
– – ﹤0.01% 3778
2022
Q1 		$815K Buy
186,971
+11,118
+6% +$43.7K ﹤0.01% 3709
2021
Q4 		$754K Buy
175,853
+18,737
+12% +$89.6K ﹤0.01% 3846
2021
Q3 		$791K Buy
157,116
+1,835
+1% +$9.54K ﹤0.01% 3810
2021
Q2 		$956K Sell
155,281
-110,264
-42% -$817K ﹤0.01% 3628
2021
Q1 		$1.94M Buy
265,545
+49,506
+23% +$422K ﹤0.01% 3262
2020
Q4 		$1.76M Buy
216,039
+68,212
+46% +$526K ﹤0.01% 3152
2020
Q3 		$1.17M Buy
147,827
+41,815
+39% +$285K ﹤0.01% 3150
2020
Q2 		$577K Buy
+106,012
New +$526K ﹤0.01% 3319

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Geode Capital Management's ETON Position: Q2 2026 in Review

Geode Capital Management increased its Eton Pharmaceutcials (ETON) stake by 13% in Q2 2026, buying an estimated $2.19M and bringing the position to 652,303 shares worth $23.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2058.

Geode Capital Management first reported a position in ETON in Q2 2020 and has held it in 25 quarters since. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Geode Capital Management held 652,303 shares of Eton Pharmaceutcials worth $23.6M as of Q2 2026.
  • Geode Capital Management bought 74,637 Eton Pharmaceutcials shares in Q2 2026, an estimated $2.19M.
  • Eton Pharmaceutcials made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2058 holding.
  • Geode Capital Management first reported a position in Eton Pharmaceutcials in Q2 2020 and has held it in 25 quarters since.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.